• John “JT” Thatch, CEO, explains expansion of SHRV in 2019 into Canada and Asia in interview at LD Micro Main Event with www.ProactiveInvestors.com, as seen on YouTube
• SHRV said that the name change will reflect its international growth strategy; in SEC filing, it says it plans for organic growth, expansion through acquisition and opportunities in other countries
• In interview, Thatch estimated that the company is on track to record sales of $50 million in 2018

Sharing Services Inc. (OTCQB: SHRV) will hold a special meeting of shareholders on January 11 for a vote to change its name to Sharing Services Global Corporation (http://ibn.fm/fln8E). John “JT” Thatch, CEO of SHRV, said that the name change would more accurately reflect the company’s international expansion moves in 2019. He discussed the company’s strategic growth into Canada and Asia in an interview with www.ProactiveInvestors.com, as seen on YouTube (http://ibn.fm/fc37I).

SHRV is a Plano, Texas-based diversified holdings company that owns, operates or controls a variety of companies engaged in direct selling through independent sales representatives. It also offers services in the energy, technology and insurance sectors. Its divisions include Elevacity Global, LLC and Elepreneur, LLC.

In its filing, the company noted that it was planning to grow both organically and by making strategic acquisitions of businesses and technologies. “The company believes there are excellent growth opportunities outside the United States, including in Canada, Mexico, Europe and Asia,” it said in the filing.

Thatch also said in the interview at the LD Micro Main Event that SHRV would report revenues of some $50 million for 2018. It had earlier recorded sales of $17.9 million for its fiscal Q2 2018 and $12.9 million revenue for Q1 2018 (http://ibn.fm/YDKEz).

For more information, visit the company’s website at www.SHRVInc.com

• Multiple breakthroughs in the field of onco-immunology are expected over the next 20 years
• BriaCell Therapeutics Corp. is a frontrunner in this area, as it has already established proof of concept for its Bria-IMT solution for advanced breast cancer patients
• The company is also developing Bria-OTS, a personalized off-the-shelf solution, that will be much easier and less costly to manufacture than comparable personalized immunotherapies

According to a report published in the British Society of Immunology, a new era has begun in the battle against cancer, as the development of immunotherapies for malignancies will take cancer treatments to a whole new level (http://ibn.fm/FRJZN). Several companies, including BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), are leading the way.

The British Society of Immunology article, part of a wider report marking 60 years of immunology, takes a brief look at the history of immunotherapies used to treat cancer, as well as the biggest limitations and expectations for the future. According to the report, this next era of cancer treatment had a major turning point with the development of monoclonal antibodies, followed by attempts to redesign T-cells, one of the body’s most important cancer fighting units. Many efforts now are directed toward the preventative aspects of immunotherapies in hope of developing a vaccine-based cure for cancer by 2020.

According to Frontiers of Immunology, a stream of breakthroughs will be observed in the field over the next 20 years (http://ibn.fm/eEbww). Immunotherapeutic approaches will be enhanced and selectively combined to help the immune system target malignancies without causing needless toxicities.

The global cancer immunotherapy market currently holds approximately 50 percent of the entire oncology therapeutics market. It generated $54 billion in 2016 and is expected to reach more than $100 billion by 2022 (http://ibn.fm/bPdce).

By 2026, immunotherapy solutions are anticipated to become the treatment of choice for various types of cancer. Estimates suggest that approximately 60 percent of previously-treated cancer patients will likely adopt an immunotherapeutic approach within this timeframe.

BriaCell Therapeutics Corp. is a Berkeley-based clinical-stage biotechnology company that’s currently focused on the development of targeted immunotherapy solutions for advanced breast cancer patients. Its primary candidate, Bria-IMT, has demonstrated excellent results in several clinical trials to date.

Bria-IMT works by providing breast cancer antigens. In addition, the treatment directly stimulates the T-cells to maximize their anti-cancer capabilities. Bria-IMT has already achieved proof of concept in clinical trials, with its safety and tolerability assessed as excellent. The effectiveness of the immunotherapy is high, as it managed to elicit tumor regression even in the case of heavily pre-treated advanced breast cancer patients.

The latest research outcomes have resulted from a combined study of Bria-IMT and KEYTRUDA (pembrolizumab) by Merck & Co. Inc. (NYSE: MRK). The combination was well tolerated in all six patients participating in the trial. This clinical trial is ongoing, and additional information about the outcomes will be provided in the first quarter of 2019, according to BriaCell Therapeutics Corp.

Apart from subjecting Bria-IMT to strenuous clinical trials, BriaCell Therapeutics Corp. is also working on the development of Bria-OTS – a personalized off-the-shelf immunotherapy solution for advanced breast cancer patients. Bria-OTS will be the first personalized immunotherapeutic solution to offer cost-effectiveness and an easier manufacturing process when compared to existing therapies.

Upon its development, Bria-OTS is expected to cover over 99 percent of the patient population. It is expected to deliver an immune response against the specific cancer tailored to each patient without necessitating a complex manufacturing and logistics process.

For more information, visit the company’s website at www.BriaCell.com

• Big corporations are investing in the cannabis industry
• Major tobacco company provides financing for LXRP
• LXRP boasts revenue streams within the nicotine industry and opportunity in other sectors
• Lexaria is a unique company doing business on its own terms

The cannabis industry is experiencing impressive growth thanks to both legal and social changes worldwide, and big corporations are stepping up to invest. In a new Audio Press Release (“APR”), CannabisNewsAudio praised Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (http://ibn.fm/sR2IL) for building a large funding deal on its own terms. The APR, ‘Outside Investment, New Technology Support Growing Cannabis Industry’, highlighted Lexaria’s ability to create subsidiaries specializing in the use of DehydraTECH.

Through the deal, Lexaria Nicotine LLC, a wholly owned subsidiary of Lexaria, has received an initial investment in the amount of $1 million – with the option for funding to increase to up to $12 million – from one of the world’s largest tobacco companies; the capital has been earmarked for research and development (http://ibn.fm/ChHLT). Lexaria will maintain its independence, while the investing company receives only minority ownership of the subsidiary. This unique arrangement allows the tobacco company to buy into LXRP without Lexaria actually selling any of its parent company.

Lexaria is strategically positioned to benefit from new revenue streams based on this deal. The company will receive royalties on any nicotine products created with DehydraTECH and be able to showcase its unique technology to other industries.

In addition to Lexaria Nicotine, LXRP has three more wholly owned subsidiaries that are working in various industries to create new deals on Lexaria’s terms.

• Lexaria CanPharm Corp. focuses on providing DehydraTECH to the global cannabis industry
• Lexaria Hemp Corp. focuses on providing DehydraTECH to the hemp-based food and supplements industry
• Lexaria Pharmaceutical Corp. focuses on licensing DehydraTECH to the pharmaceutical sectors

DehydraTECH is a drug-delivery platform patented for cannabidiol and all other non-psychoactive cannabinoids, as well as THC (tetrahydrocannabinol) and psychoactive cannabinoids. The technology is an enabling platform that works across multiple industries, thereby providing a large base of consumers with healthier forms of consumption than lighting up.

LXRP and DehydraTECH stand out among the competition. The company has a total of 10 patents issued with more than 50 patents pending worldwide. Few companies within the cannabis industry have attracted the attention of Fortune 500-type corporations, and even fewer are inking deals on their own terms. Lexaria Bioscience is one such stand-out.

For more information, visit the company’s website at www.LexariaBioscience.com

• Effective February 4, Supreme Cannabis securities began trading on the Toronto Stock Exchange
• Supreme is focusing on pursuing opportunities in the emerging global cannabis market and generating sustainable growth
• Supreme’s wholly owned subsidiary, 7ACRES, cultivates craft-quality cannabis on a commercial scale

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF) (FRA: 53S1) has started trading on the Toronto Stock Exchange (“TSX”). Effective February 4, the company’s listed securities began trading under ticker symbols ‘FIRE’ and ‘FIRE.DB’ (http://ibn.fm/ENb2b).

This move is designed to support the company’s strategy of targeting premium brands, leverage its coast-to-coast distribution in Canada and aid in its expansion into the international cannabis market. The company will also focus on generating sustainable growth. The company’s common shares and senior unsecured convertible debentures due in 2021 were voluntarily delisted from the TSX Venture Exchange when trading began on the TSX.

The move to the TSX comes as the company’s future looks especially promising. Supreme estimates that its annual production target will grow early this year to full capacity, from its current 17,500-50,000 kg. (http://ibn.fm/i8OMC). The company is focused on penetrating the global cannabis market. Supreme sees its marketing effort in Canada – where it has achieved national wholesale distribution, operated retail stores and offers online availability – as especially appealing to legal-aged cannabis enthusiasts (“LACE”).

The Toronto-based company plans to grow in what it sees as an emerging global market and seeks to expand by satisfying the needs of LACE consumers for premium cannabis. Supreme is focused on producing quality product that commands higher price points than competitors. The company is deploying a timing strategy of “first in, wins,” when it comes to national listing success.

Supreme’s wholly owned subsidiary, 7ACRES, operates a 440,000-square-foot facility in Ontario, where it cultivates craft-quality cannabis on a commercial scale. The one-of-a-kind hybrid greenhouse uses advanced HVAC and CO2 enrichment, combining the best practices of indoor cannabis cultivation with the power of the sun.

In addition, Supreme has a long-term global distribution partnership agreement with Lesotho-based Medigrow for the export of medical-grade cannabis oil to Canada and other international markets.

For more information, visit the company’s website at www.Supreme.ca

• Targeted global markets include $1.43 billion nematicide industry, $9.5 billion biopesticide industry
• Economic impact of crop damage caused by soil-borne nematodes estimated at $100 billion worldwide
• The EPA has banned most synthetic fumigant nematicides and is also restricting the use of non-fumigant nematicides
• Consumer demand for organic products has increased the need for sustainable, green solutions
• Currently finalizing development of AITC liquid concentrate for drip line delivery platform
• Testing underway for potential application as a natural pre-plant soil treatment in the cannabis industry
• Based on third-party studies, MustGrow’s technologies deliver superior pest and pathogen control compared to harmful synthetic chemicals that are being banned

MustGrow Biologics Corp. is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.

Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients (http://ibn.fm/0AnvA). For the past 50 years, nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical formulations.

MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://ibn.fm/SlUtJ), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.

MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.

MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.

Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:

• 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
• 55 percent tomato crop yield increase
• 95 percent control of Pythium root rot in lettuce fields
• 70 percent reduction in Verticillium root severity in cucumbers
• Market Opportunity

Market Opportunity  

MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers. MustGrow’s potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.

Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated $9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.

MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.

Management Team

President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries. Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.

Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.

COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.

Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis (TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.

Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.

CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.

For more information, visit the company’s website at www.MustGrow.ca

• The e-commerce platform will incorporate Pacific Software’s Agri-Blockchain technology, as well as IoT solutions to increase transparency and safety
• In its annual letter to shareholders, Pacific Software outlined a number of additional financial and company development goals accomplished throughout 2018
• Based on its rapid growth, the company expects to maintain the speed of development through 2019 and to implement a business plan focused on further expansion

Business development technology innovator Pacific Software Inc. (OTC: PFSF) anticipates the launch of its cross-border Brazil-China ecommerce trade platform in Q1 2019, as the company announced in a recently-issued shareholder letter (http://ibn.fm/0At7w). The letter outlines the company’s biggest accomplishments and milestones in 2018. It also sheds some light on future goals and anticipated developments for 2019.

The e-commerce platform is currently in the process of being developed. It will be a digital, blockchain-supported e-commerce website that will link Brazilian agricultural suppliers to China. Pacific Software’s Agri-Blockchain technology will be incorporated to increase the transparency of transactions and guarantee trust in the origin, quality and safety of products.

Additionally, Pacific Software is working toward the integration of Internet of Things (“IoT”) solutions with the platform. Such capabilities are expected to enable the extraction of data derived from Internet-connected devices like barcode readers. This way, the e-commerce platform will accumulate valuable product data to ensure effective supply chain management.

The annual shareholder letter also highlighted the key Pacific Software milestones of 2018. During the year, the company opened an office in Hong Kong and incorporated HyperSoft Ventures as a wholly owned subsidiary. The subsidiary may host the B2B cross border e-commerce platform and procure clients as an application service provider.

An audited financial statement was completed in 2018, as the company’s also considering an uplisting to the OTCQB Venture Market or other stock trading platforms. The company’s revenue model has manifested in the form of a monthly subscriber fee for basic functionality, higher fees for premium functionality, variable fees for marketing tools, revenue sharing with platform partners and transaction fees for collective product orders.

As far as 2018 accomplishments go, Pacific Software also announced that it has completed the development of e-commerce platform solutions and features for the company’s subscribers. Some of these features include smart contracts, digital marketing, customs levies, search/match applications, blockchain solutions, advertising and more.

The shareholder letter concluded with a brief statement outlining plans for 2019 and beyond, underlining Pacific Software’s commitment to work hard as to maintain the rapid pace of development from 2018. The business plan provides for further expansion into the commercial markets of Brazil and China with product, business and staffing development.

Pacific Software is an emerging development technology corporation that focuses on investments, mergers and acquisitions of software-based technological solutions and platforms. The company boasts a major strength in terms of B2B and B2C e-commerce blockchain solutions development – its utilization of the IBM Hyperledger Blockchain Backend as a Service (“BaaS”) infrastructure. The Pacific Software trade platforms is expected to improve product traceability and digitize the trade process.

For more information, visit the company’s website at www.PacificSoftwareInc.com

• President of ETST’s partner for the manufacturing of Hygee attended fair with Quebec delegation
• Launch of Hygee, which tests women for sexually transmitted infections, is expected in first half of this year
• ETST recently launched an international marketing campaign for the device

Earth Science Tech Inc. (OTCQB: ETST), a biotech company that markets and develops hemp cannabinoid products, plans to introduce its Hygee medical testing kit in the first half of this year. As part of that strategy, the company showed Hygee at Arab Health 2019, the largest annual medical trade fair in the Middle East and North Africa (“MENA”) region (http://ibn.fm/KMW9t).

ETST has formed a strategic partnership for Hygee’s manufacture with Dermagate, a company that specializes in the production of dermatology and wound-care products. Gaétan Houle, president of Dermagate, represented ETST at Arab Health 2019 and was accompanied by an eight-company delegation organized by the Quebec Minister of the Economy and Innovation. Houle was also scheduled to attend a reception at the Canadian Consulate and meet with other Canadian trade ministers based in MENA countries.

Hygee is a medical self-sampling kit designed for women to use in the detection of STIs, starting with chlamydia. Dr. Michel Aubé, ETST’s CEO and chief science officer, said in a news release that the company’s goal at the show was to make key business contacts and connect to the MENA region’s health care industry and market.

In a news release, Houle said, “As previously announced, Hygee is on its way to being certified ISO-13485, and soon after, it will be licensed by the U.S. FDA and Health Canada. Moreover, ETST will apply for licensing Hygee in at least five other countries. This is notable, as many of North America’s largest medical device companies will attend Arab Health 2019, as will manufacturers and distributors from around the world.” An estimated 4,000 companies from 66 countries were scheduled to attend the fair, showing products and services to more than 84,000 visitors and nearly 6,000 dignitaries.

Based in Doral, Florida, ETST produces and sells CBD products, as well as dietary supplements for the pharmaceutical and nutraceutical fields. The company is focused on the cannabidiol, pharmaceutical and nutraceutical sectors, as well as the development, through subsidiaries, of medical devices and research. ETST’s goal is to become a world leader in the CBD space.

ETST holds several wholly owned subsidiaries. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures and distributes in the recreational sector. Earth Science Foundation Inc. is becoming a nonprofit and accepts grants and donations to conduct studies. Earth Science Pharmaceutical develops medical diagnostic tools and vaccines, while Canna Inno Laboratories Inc. provides ETST with access to government grants.

For more information, visit the company’s website at www.EarthScienceTech.com

• 5G network services have been tested in the United States, with rollout anticipated by next year
• The 5G networks are expected to boost speeds another 2,000 percent beyond current 4G LTE standards
• Spectrum Global Solutions provides end-to-end network services for the telecommunications giants leading the 5G charge, as well as large “aggregators”
• SGSI anticipates that $150 billion to $200 billion will be spent on network deployment services alone “over the next couple of years”

The world has heard the first shot heralding the coming mobile technology revolution that will sweep in 5G network speeds and a host of new Internet of Things (“IoT”) capabilities, and telecommunications network end-to-end service provider Spectrum Global Solutions Inc. (OTCQB: SGSI) is gaining attention as the echo reverberates throughout the industry.

“The larger companies that may need our services find us attractive because, one, we’ve got an excellent safety record — actually a 100 percent safety record,” SGSI President Keith Hayter told The RedChip Money Report during an interview last month (http://ibn.fm/K5Qtf). “We have national engineering licenses throughout the U.S., Canada and into the Caribbean. We’re able to provide that comprehensive set of services so it’s a one-source engagement with our customers that mitigates the need to hire multiple contractors to perform multiple services — not just across the nation, but they may only need them in specific locations.”

Spectrum Global Solutions lists some 200 clients ranging from multinational telecommunications giants such as Sprint, AT&T and Verizon to large infrastructure “aggregators” such as Crown Castle, ExteNet Systems and Uniti Fiber, providing services “for the installation, construction and maintenance of next-generation infrastructure for telecommunication networks,” Hayter said.

The company’s third quarter report noted a 300 percent year-over-year increase in revenues and a 200 percent quarterly increase in net income, and SGSI expects the forecast to remain robust as businesses and consumers alike clamor for 5G capability as the large carriers begin to roll out new infrastructure.

“The market opportunity is immense,” Hayter continued. “Over $1.5 trillion is going to be spent on telecommunications. For deployment services, which is where we primarily fit in and get our revenue streams from, from $150 (billion) to $200 billion will be spent over the next couple of years.”

AT&T and Verizon are racing to establish 5G service in the United States and gain consumers’ attention. AT&T’s introduction of a “5G E” icon on mobile phones has been widely mocked because of its apparent deception in convincing consumers that they already have 5G service speeds (http://ibn.fm/ybDe9), but the company defends its “5G Evolution” promotion as a means of informing mobile users if they are located in the 400-and-counting markets where 5G service is expected to go live next year.

AT&T tested its 5G network in a dozen cities around the country late last year, and Verizon announced that it was introducing a limited home broadband service with 5G speeds in a handful of other markets (http://ibn.fm/Fd616). In the United Kingdom, a telecommunications partnership is working on a test to broadcast 5G service to rural areas that might otherwise get bypassed by the revolutionary tech. The “5G RuralFirst” initiative is planning to test uniquely rural-focused uses of 5G, such as a test of IoT-enabled autonomous tractors that can run at all hours of the day, as well as distance monitoring of a salmon fishery (http://ibn.fm/DY4dV).

While no 5G-enabled consumer devices have hit the market yet, smartphone makers wait with anticipation for the rollout of new product lines, and media outlets build expectations for services offering 20-times faster data transmission speed than the current 4G LTE network, as well as better support for artificial intelligence and virtual reality.

For more information, visit the company’s website at www.SpectrumGlobalSolutions.com

• The company has entered into an agreement with a syndicate of agents that will be engaged in the private placement sale; the syndicate is led by Canaccord Genuity Corp.
• A single unit is comprised of one C$1,000 unsecured note that accrues annual interest and 77 common share purchase warrants of Plus Products
• The proceeds will be used for working capital and other corporate purposes

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF), a leading branded products manufacturer, recently announced that it has entered into an agreement with a syndicate of agents concerning the private placement of unsecured convertible note units, according to a company news release (http://ibn.fm/A29FJ).

The agents, led by Canaccord Genuity Corp. (TSX: CF), have been engaged by Plus Products to sell unsecured convertible note units of up to C$20 million on a private placement basis. Each unit of the company is offered at a price of C$1,000.

A single unit is comprised of one C$1,000 principal amount unsecured note. The note accrues annual interest of eight percent, payable semi-annually in arrears until maturity. Each convertible note will have a maturity date of 24 months from the closing date of the offering. The unit also includes 77 common share purchase warrants of Plus Products.

Every note is convertible into common Plus Products capital shares. The price per conversion share is $6.50 commencing on the date set at exactly one year after the issuance of the note.

The principal amount of the convertible note may be turned into conversion shares at a price equal to the greater of either 95 percent of the volume weighted average price for the Plus Products common shares listed on the Canadian Securities Exchange for the 30-day period right before the conversion date or the conversion price.

Each note will be convertible in tranches that are defined as: one tranche of 33.3 percent starting on the 12-month anniversary of the offering date; a second tranche of 33.3 percent commencing on the 18-month anniversary of the offering date and a final tranche of 33.3 percent that starts at the 24-month anniversary.

Each warrant enables its holder to acquire one common share of Plus Products capital. The exercise price is set at $8 per warrant for a period of five years commencing at the date of the offering. When exercised within the first year, the underlying shares will be subject to a contractual hold of 365 days.

The convertible notes will be unsecured Plus Products obligations. The syndicate of agents has been granted an option to purchase an additional 3,000 convertible note units at any time in the 48 hours before the offering date. These additional convertible note units represent 15 percent of the gross proceeds.

The offering’s closing date is anticipated on February 19, 2019.

All proceeds from the offering will be used for the generation of Plus Products working capital, as well as for additional corporate purposes.

Plus Products is one of the leading edibles brands in California, where it ranked as the number one edibles branch in Q3 2018 (http://ibn.fm/CN0Em). The company’s product rage consists of cannabis-infused edibles that sell on both the regulated medicinal and adult-use recreational markets. Plus Products is currently one of the fastest-growing edible companies in the Golden State.

The company aims to make cannabis approachable and safe by focusing on manufacturing high-quality products and continuing to pursue innovation in the cannabis-infused edibles niche.

For more information, visit the company’s website at www.PlusProducts.com

• Pacific Software is working to facilitate trade between China and Brazil, breaking new ground for the two largest countries on their respective continents
• A newly-announced partnership with a Brazilian trade organization in the Amazon region state of Rondônia is expected to provide an international network for businesses there
• The company’s BOAPIN e-commerce platform is on pace to be completed within the coming weeks, providing a blockchain-based supply management utility
• Pacific Software’s portal and trade platform will also create solutions for smart contracts, digital marketing and digital finance needs

Emerging technology development company Pacific Software Inc. (OTC: PFSF) is building a framework to enhance international trade for South American businesses, beginning in the Amazonian interior of the continent with a newly-announced partnership that will promote ties between a Brazilian trade organization’s members and Chinese markets (http://ibn.fm/fGVMc).

The agreement will allow the 7,500-plus members of the Federation of the Industries of the State of Rondônia (“FIERO”) to enlist as subscribers to Pacific Software’s in-development BOAPIN platform, a cross-border, multifaceted, B2B and B2C e-commerce resource designed to improve the standards of international commodities trade. In the case of the import/export market between Brazil and China, the platform is helping to establish a ‘Digital Silk Road’ connecting producers and buyers, particularly for agricultural commodities.

The global agriculture industry is increasingly becoming the focus of some market uneasiness, as scientists and consumers alike express fears about land use policies, environmental impacts and population health crises. One world policy researcher referred to current industrial practices as “unsustainable” (http://ibn.fm/zAWFN), while, in Germany, a large group of protesters from diverse parts of the country recently used an international agricultural fair to voice their concerns about large-scale farming (http://ibn.fm/3ciSN) and imbalances hindering smaller growers’ operations. Technological innovations have become critical to responding to the global challenges people face (http://ibn.fm/LYfGY), and the trend has created a market space for businesses such as Pacific Software Inc.

Pacific Software’s focus on developing an e-commerce platform to improve the standards of international commodities trade is expected to create an unprecedented best practices potential. In the process, the company is making it easier for producers of differing sizes within the largest countries on their respective continents to compete for space based on the quality of their products and their processes (http://ibn.fm/yIJIy), using smart contract technology to improve product certification, market data analysis, commodities searches and cross-border payment avenues.

China has been the world’s leading trading nation for much of the past decade, surpassing the United States in many quarters (http://ibn.fm/Kvkng). In 2016, China exported $2.3 trillion worth of commodities and imported $1.2 trillion. The country’s gross domestic product that year was $11.2 trillion, and its GDP per capita was $15,500 (http://ibn.fm/b1sig). The European Union, Asian nations and the United States have been China’s primary trade partners, but the United States has created new hurdles for its trade relationship with China during the last couple of years, and Pacific Software’s role in boosting Brazilian trade could be just the beginning of a sea change for multiple South American nations.

In July, Pacific Software signed a letter of intent with the governor’s office of Rondônia, declaring a mutual interest in promoting exporters to China (http://ibn.fm/mHAZf). The FIERO subscription agreement, announced on January 29, provides “opportunities and functionalities not readily available with current supply chain solutions” for the Brazilian agricultural businesses, and BOAPIN’s China-based social marketing program will strengthen the branding of goods from Rondônia by streamlining information shared through international trade.

“We are pleased to partner with Pacific Software and leverage its trade portal BOAPIN.com to promote regional business of Rondônia,” FIERO Chairman Marcelo Thomé da Silva de Almeida stated in a news release. “Together we aim to further the reach of the great products from our region.”

The BOAPIN platform is set for launch during the first quarter of this year, and the service’s website is currently under development (http://ibn.fm/qjWt9), according to PFSF. The platform will store product information digitally while ensuring tracking and recording capabilities through the Internet of Things. IBM’s Hyperledger Blockchain Backend as a Service (“BaaS”) infrastructure provides the technological power behind BOAPIN.

For more information, visit the company’s website at www.PacificSoftwareInc.com